OX40 expressed on activated T cells is known to be an important costimulatory molecule on T cell activation in vitro. However, the in vivo functional significance of the interaction between OX40 and its ligand, OX40L, is still unclear. To investigate the role of OX40L during in vivo immune responses, we generated OX40L-deficient mice and a blocking anti-OX40L monoclonal antibody, MGP34. OX40L expression was demonstrated on splenic B cells after CD40 and anti-immunoglobulin (Ig)M stimulation, while only CD40 ligation was capable of inducing OX40L on dendritic cells. OX40L-deficient and MGP34-treated mice engendered apparent suppression of the recall reaction of T cells primed with both protein antigens and alloantigens and a significant reduction in keyhole limpet hemocyanin–specific IgG production. The impaired T cell priming was also accompanied by a concomitant reduction of both T helper type 1 (Th1) and Th2 cytokines. Furthermore, antigen-presenting cells (APCs) derived from the mutant mice revealed an impaired intrinsic APC function, demonstrating the importance of OX40L in both the priming and effector phases of T cell activation. Collectively, these results provide convincing evidence that OX40L, expressed on APCs, plays a critical role in antigen-specific T cell responses in vivo.
Skip Nav Destination
Article navigation
17 January 2000
Article|
January 17 2000
Impairment of Antigen-Presenting Cell Function in Mice Lacking Expression of Ox40 Ligand
Kazuko Murata,
Kazuko Murata
aDepartment of Microbiology and Immunology, Tohoku University School of Medicine, Sendai 980-8575, Japan
bCore Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Kawaguchi 332-0012, Japan
Search for other works by this author on:
Naoto Ishii,
Naoto Ishii
aDepartment of Microbiology and Immunology, Tohoku University School of Medicine, Sendai 980-8575, Japan
Search for other works by this author on:
Hiroshi Takano,
Hiroshi Takano
dDepartment of Cell Biology, Cancer Institute, Toshima-ku, Tokyo 170, Japan
Search for other works by this author on:
Shigeto Miura,
Shigeto Miura
aDepartment of Microbiology and Immunology, Tohoku University School of Medicine, Sendai 980-8575, Japan
bCore Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Kawaguchi 332-0012, Japan
Search for other works by this author on:
Lishomwa C. Ndhlovu,
Lishomwa C. Ndhlovu
aDepartment of Microbiology and Immunology, Tohoku University School of Medicine, Sendai 980-8575, Japan
Search for other works by this author on:
Masato Nose,
Masato Nose
cSecond Department of Pathology, Ehime University School of Medicine, Ehime 791-02, Japan
Search for other works by this author on:
Tetsuo Noda,
Tetsuo Noda
bCore Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Kawaguchi 332-0012, Japan
dDepartment of Cell Biology, Cancer Institute, Toshima-ku, Tokyo 170, Japan
Search for other works by this author on:
Kazuo Sugamura
Kazuo Sugamura
aDepartment of Microbiology and Immunology, Tohoku University School of Medicine, Sendai 980-8575, Japan
bCore Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Kawaguchi 332-0012, Japan
Search for other works by this author on:
Kazuko Murata
aDepartment of Microbiology and Immunology, Tohoku University School of Medicine, Sendai 980-8575, Japan
bCore Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Kawaguchi 332-0012, Japan
Naoto Ishii
aDepartment of Microbiology and Immunology, Tohoku University School of Medicine, Sendai 980-8575, Japan
Hiroshi Takano
dDepartment of Cell Biology, Cancer Institute, Toshima-ku, Tokyo 170, Japan
Shigeto Miura
aDepartment of Microbiology and Immunology, Tohoku University School of Medicine, Sendai 980-8575, Japan
bCore Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Kawaguchi 332-0012, Japan
Lishomwa C. Ndhlovu
aDepartment of Microbiology and Immunology, Tohoku University School of Medicine, Sendai 980-8575, Japan
Masato Nose
cSecond Department of Pathology, Ehime University School of Medicine, Ehime 791-02, Japan
Tetsuo Noda
bCore Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Kawaguchi 332-0012, Japan
dDepartment of Cell Biology, Cancer Institute, Toshima-ku, Tokyo 170, Japan
Kazuo Sugamura
aDepartment of Microbiology and Immunology, Tohoku University School of Medicine, Sendai 980-8575, Japan
bCore Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Kawaguchi 332-0012, Japan
Abbreviations used in this paper: EAE, experimental autoimmune encephalomyelitis; ES, embryonic stem; HEL, hen egg lysozyme; s, soluble.
Received:
August 10 1999
Revision Requested:
November 01 1999
Accepted:
November 04 1999
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Exp Med (2000) 191 (2): 365–374.
Article history
Received:
August 10 1999
Revision Requested:
November 01 1999
Accepted:
November 04 1999
Citation
Kazuko Murata, Naoto Ishii, Hiroshi Takano, Shigeto Miura, Lishomwa C. Ndhlovu, Masato Nose, Tetsuo Noda, Kazuo Sugamura; Impairment of Antigen-Presenting Cell Function in Mice Lacking Expression of Ox40 Ligand. J Exp Med 17 January 2000; 191 (2): 365–374. doi: https://doi.org/10.1084/jem.191.2.365
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement